A newly designed antibiotic called tedizolid
phosphate, taken once daily for 6 days to skin, has proved effective at
combating skin diseases.
The tedizolid phosphate antibiotic has been used in
trials for complicated skin and skin structure infections (SSSIs),
according to Monthly Prescribing Reference.
One of the concerns with available oral antibiotics is that more and
more microorganisms are becoming resistant to their use (which is
probably due to the over prescription of various antibiotics for a range
of different illnesses). This is leading scientists to search for new
classes of antibiotics. Another issue relates to the time taken for
treatment of many skin conditions, which is around tend days.
The antibiotic was studied, as the research brief
outlines, through a clinical trial. For this a randomized trial was
conducted from August 2010 through September 2011 at 81 study centers in
North America, Latin America, and Europe. The trial used tedizolid
phosphate and compared it to other treatments already available on the
market.
The outcome of the trial was that tedizolid phosphate achieved the
desired effect (improving the skin condition by eliminating the
microbial infection) in around six days compared with a time of ten days
taken for the comparative antibiotic.
The research has been published in the journal JAMA (The Journal of the American Medical Association).
Read more: http://www.digitaljournal.com/article/343489#ixzz2LMy1cDwU
Nenhum comentário:
Postar um comentário